Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03694262
Title The EndoBARR Trial (Endometrial Bevacizumab, Atezolizumab, Rucaparib) (EndoBARR)
Acronym EndoBARR
Recruitment Completed
Gender female
Phase Phase II
Variant Requirements No
Sponsors Medical College of Wisconsin
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.